Erlotinib 59651-0532-03

Package NDC

59651-0532-03

Manufacturer: Aurobindo Pharma Limited
Dosage Form: Tablet, Film Coated
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: June 22, 2022
Listing Expires: December 31, 2026
Application: ANDA216342

Need to source Erlotinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Erlotinib Hydrochloride	150 mg/1

Drug Class

Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]

Selected Package

59651-0532-03Selected

30 TABLET, FILM COATED in 1 BOTTLE (59651-532-03)

Other packages for this product(1)

59651-0532-10

1 BLISTER PACK in 1 CARTON (59651-532-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK

View →